Tìm theo
659032
Thuốc Gốc
Small Molecule
659032 is the third genomics-derived small-molecule drug coming from a collaboration between Human Genome Sciences and GlaxoSmithKline to enter clinical development. 659032 is a second lipoprotein-associated phospholipase A2(Lp-PLA2) inhibitor.
Cơ Chế Tác Dụng : 659032 is the third genomics-derived small-molecule drug coming from a collaboration between Human Genome Sciences and GlaxoSmithKline to enter clinical development. 659032 is a second lipoprotein-associated phospholipase A2(Lp-PLA2) inhibitor. Lp-PLA2 is an enzyme associated with the formation of atherosclerotic plaques.
Chỉ Định : Cardiovascular Disorders and Atherosclerosis
Tài Liệu Tham Khảo Thêm
drugbank
http://www.drugbank.ca/drugs/DB05256
... loading
... loading